Oncimmune (ONC) News Today GBX 15.15 +0.05 (+0.33%) (As of 11/21/2024 ET) Add Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Oncimmune Holdings shares tick up as notes new contractsOctober 31, 2024 | lse.co.ukUPDATE: Oncimmune raises GBP2.2 million in equity as plannedOctober 21, 2024 | lse.co.ukSMALL CAP MOVERS: Pulsar Helium lifted by £5m IPO fundraiseOctober 18, 2024 | msn.comCancer Biopsy Market to Reach USD 85.03 Billion by 2032, Driven by Rising Cancer Incidence and Advances in Liquid Biopsy TechnologiesOctober 9, 2024 | finance.yahoo.comOncimmune Holdings plc (ONC.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comOncimmune expects "substantial" revenue growth following contract winsSeptember 9, 2024 | lse.co.ukOncimmune Holdings agrees new contract valued at USD700,000September 2, 2024 | lse.co.ukOncimmune Holdings PLC ONCAugust 6, 2024 | morningstar.comAnalysts Expect Breakeven For Oncimmune Holdings plc (LON:ONC) Before LongMay 26, 2024 | finance.yahoo.comEARNINGS AND TRADING: Topps Tiles in strategic shift as swings to lossMay 21, 2024 | lse.co.ukOncimmune Holdings PLC (ONCON)May 17, 2024 | investing.comOncimmune Holdings PLCMarch 19, 2024 | wsj.comOncimmune Holdings Full Year 2023 Earnings: UK£0.085 loss per share (vs UK£0.13 loss in FY 2022)March 2, 2024 | finance.yahoo.comCancer test firm Freenome raises $254 mln in fresh fundingFebruary 15, 2024 | reuters.comActivist investor Kelso gains board seats at The Works as it tries to enhance shareholder valueFebruary 14, 2024 | msn.comOncimmune seeing commercial traction as it inks new deals with big pharma companiesDecember 2, 2023 | proactiveinvestors.com.auThe Unique Use of Liquid BiopsySeptember 26, 2023 | yahoo.comOncimmune's Acting CEO Ron Kirschner Steps Down, Takes COO Role; Gouldstone Starts as CEOAugust 1, 2023 | marketwatch.comOncimmune Shares Fall As Company Lowers FY 2022 Revenue ResultJuly 14, 2023 | marketwatch.comOncimmune names chief executive successor, while finance chief leavesJuly 12, 2023 | lse.co.ukOncimmune Holdings Appoints Martin Gouldstone CEO; CFO Matthew Hall to Step DownJuly 12, 2023 | marketwatch.comOncimmune Holdings shakes up leadership and unveils new growth planJune 23, 2023 | lse.co.ukOncimmune CEO Adam Hill to Step Down; Sees Tough End to FY 2023June 23, 2023 | marketwatch.comOncimmune shares plummet as interim revenue falls by fifthMay 31, 2023 | lse.co.ukOncimmune Shares Fall on 1H Pretax LossMay 31, 2023 | marketwatch.comOncimmune sells two subsidiaries to Freenome for GBP13 millionMay 22, 2023 | lse.co.ukFREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTDMay 22, 2023 | markets.businessinsider.comOncimmune Eases Going-Concern Risk With Sale of Two Subsidiaries for GBP13 MlnMay 22, 2023 | marketwatch.comThe Comprehensive Guide to the Cancer Biopsy Market: Trends and Revenue Forecast with predicted CAGR of 4.2% from 2023-2030April 28, 2023 | marketwatch.comCancer Biopsy Market Outlook by 2031April 22, 2023 | marketwatch.comOncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual ConferenceApril 12, 2023 | finance.yahoo.comOncimmune delivering top-line growthFebruary 28, 2023 | proactiveinvestors.comOncimmune Shares Fall After Going Concern Warning, Pretax LossFebruary 27, 2023 | marketwatch.comCORRECT: Oncimmune works with Siemens Healthineers on cancer therapyFebruary 20, 2023 | lse.co.ukRichard Sharp: BBC chair was shareholder in firm awarded £600k while he was a No 10 adviserJanuary 25, 2023 | theguardian.comInvestors in Oncimmune Holdings (LON:ONC) have unfortunately lost 67% over the last yearJanuary 2, 2023 | finance.yahoo.comOncimmune Holdings to Raise at Least GBP2.1 Mln; Mulls EarlyCDT IPODecember 7, 2022 | marketwatch.comInstitutional investors own a significant stake of 48% in Oncimmune Holdings plc (LON:ONC)October 13, 2022 | finance.yahoo.comOncimmune shares plummet as company reports widened pretax lossSeptember 21, 2022 | lse.co.ukOncimmune FY 2022 Pretax Loss Widens on Higher Costs; Shares FallSeptember 21, 2022 | marketwatch.comOncimmune Holdings Plc (ONC.L)September 2, 2022 | uk.finance.yahoo.comEstimating The Fair Value Of Oncimmune Holdings plc (LON:ONC)July 31, 2022 | finance.yahoo.comFurther weakness as Oncimmune Holdings (LON:ONC) drops 12% this week, taking one-year losses to 56%June 16, 2022 | finance.yahoo.comGlobal Cancer Biopsy Market to Reach USD 43,692 Million | Growing at CAGR of 10.7% | Insights and Tools and Forecast 2028June 2, 2022 | benzinga.comOncimmune receives 2022 Queen's Award for EnterpriseApril 21, 2022 | proactiveinvestors.com.auFTSE 100 ends the week higher as Wall Street also recoversApril 8, 2022 | proactiveinvestors.com.auFTSE follows US rally while Elon Musk faces potential SEC probe and UK starting salaries riseApril 8, 2022 | proactiveinvestors.comOncimmune agrees two new commercial contractsApril 8, 2022 | lse.co.ukOncimmune lands follow-on Covid study contractMarch 7, 2022 | proactiveinvestors.com.auOncimmune Holdings Wins Follow-On Contract for Covid-19 StudyMarch 7, 2022 | marketwatch.com Get Oncimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼1.140.46▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼00▲ONC Articles Average Week Get Oncimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ONC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts